Global Narcolepsy Market Research Report, By Type (Type 1, Type 2 Narcolepsy) Diagnosis (Poysomnogram, Multiple Sleep Latency Test) Treatment (Stimulants, Antidepressants, Sodium Oxybate) End Users (Hospitals, Retail Pharmacies) – Global Forecast Till 2027
Market Highlights
Rising narcolepsy prevalence and increasing obese population are the key drivers of growth in the narcolepsy market during the forecast period. Growing demands for efficient clinical care accompanied by rising research and development are also driving the growth of the narcolepsy industry.
However, it is projected that a lack of understanding and low per capita healthcare spending across middle and low-income countries' geographical borders restrict the global demand for narcolepsy during the forecast period. Moreover, lack of knowledge and low healthcare expenditure per capita in middle and low-income countries may limit the growth of the global narcolepsy market during the forecast period.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5701
Market Segmentation
On the basis of the type, the narcolepsy market is segmented into type 1 narcolepsy, type 2 narcolepsy, and others.
On the basis of the diagnosis, the narcolepsy market is categorized into polysomnogram, multiple sleep latency tests, others.
On the basis of the treatment, the market is segmented into stimulants, antidepressants, sodium oxybate, and others.
Regional Analysis
America leads the global market for narcolepsy due to a well-developed healthcare system, enormous healthcare spending, and a massive patient population. According to the 2018 National Institution of Neurological Diseases and Stroke, about 135,000 to 200,000 individuals in the United States are estimated to be dealing with narcolepsy. In addition, the presence of developing economies such as the U.S. and Canada, and foreign competitors such as Mylan N.V., Ligand Pharmaceuticals, Inc., and others across America's geographic borders drives demand growth in narcolepsy.
Europe is the second-largest narcolepsy market and is led by the Asia Pacific due to the availability of research funding, a large patient demographic, a rising number of obese, and the involvement of developing economies such as France, Italy, and Germany in the region. For the past few years, Europe has led the regional industry in terms of sales. The reasons that can be attributed to its largest share are the large affected population, well-established healthcare system, and increasing R&D initiatives for the production of novel drugs. In Europe, the H1N1 influenza pandemic led in 2009 to a spike in sleep-related disorders.
It is projected that the Asia Pacific is the fastest developing region in the global narcolepsy market. On the other hand, Asia Pacific is expected to experience lucrative growth over the projected period due to economic progress, increasing recognition among people, high disposable income, rising investment in the pharmaceutical & biotechnology industries, and supporting government initiatives. The existence within the area of emerging economies such as India and China, and the expansion of the healthcare sector, promote regional market growth. Additionally, supportive government policies are stimulating growth in the narcolepsy industry. Japan is classified as one of the highly prevalent regions of the Asia Pacific narcolepsy market. In addition, The booming generics sector and the upgrade of healthcare services are likely to drive more demand growth in the immediate future. However, a large number of undiagnosed cases in this area continue to be a significant concern for this market's growth.
The Middle East & Africa has the least share of the international market for narcolepsy. Factors such as the prevalence of depressed economies and strict government policies in the African region, in particular, make the demand lagging within the region. The Middle East holds a large market share in the Middle & Africa region. The involvement of developing economies such as Saudi Arabia, Kuwait may attribute this to a massive healthcare expense within the region.
Competitive Dashboard
BIOPROJET (Paris), Arena Pharmaceuticals, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Shionogi Inc. (U.S.), Novartis AG (Switzerland), Shire (Republic of Ireland), Mylan N.V. (U.S.), Ligand Pharmaceuticals, Inc. (U.S.), Graymark Healthcare, Inc. (U.S.), Jazz Pharmaceuticals plc (Republic of Ireland), and others.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/narcolepsy-market-5701
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
Global Narcolepsy Market Research Report, By Type (Type 1, Type 2 Narcolepsy) Diagnosis (Poysomnogram, Multiple Sleep Latency Test) Treatment (Stimulants, Antidepressants, Sodium Oxybate) End Users (Hospitals, Retail Pharmacies) – Global Forecast Till 2027Market HighlightsRising narcolepsy prevalence and increasing obese population are the key drivers of growth in the narcolepsy market during the forecast period.
Growing demands for efficient clinical care accompanied by rising research and development are also driving the growth of the narcolepsy industry.However, it is projected that a lack of understanding and low per capita healthcare spending across middle and low-income countries' geographical borders restrict the global demand for narcolepsy during the forecast period.
Moreover, lack of knowledge and low healthcare expenditure per capita in middle and low-income countries may limit the growth of the global narcolepsy market during the forecast period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5701Market SegmentationOn the basis of the type, the narcolepsy market is segmented into type 1 narcolepsy, type 2 narcolepsy, and others.On the basis of the diagnosis, the narcolepsy market is categorized into polysomnogram, multiple sleep latency tests, others.On the basis of the treatment, the market is segmented into stimulants, antidepressants, sodium oxybate, and others.
Regional AnalysisAmerica leads the global market for narcolepsy due to a well-developed healthcare system, enormous healthcare spending, and a massive patient population.
According to the 2018 National Institution of Neurological Diseases and Stroke, about 135,000 to 200,000 individuals in the United States are estimated to be dealing with narcolepsy.
For the past few years, Europe has led the regional industry in terms of sales.
Global Peripheral Nerve Stimulators Market Research Report: Information by Product (Transcutaneous, Implantable), End User (Hospitals & Clinics, Ambulatory Centers, Specialty Center), Region (Americas, Europe, Asia Pacific, Middle East & Africa) - Forecast till 2027Market HighlightsGlobal peripheral nerve stimulators market expected to grow significantly over the forecast period.
It is anticipated that the market held a market value of USD 750.36 million in 2018 and is projected to grow at a CAGR of 7.7% over the forecast period.
Peripheral Nerve Stimulators is expected to grow at a significant growth rate.
The major factors influencing the growth of the market include; rising economic growth, increasing geriatric devices, increasing growth in technological advancement in the field of medical devices, rising neurological disorders, rising incidence of chronic health problems, and others.SegmentationThe global peripheral nerve stimulators market has been segmented into product, and end user.Based on product, the market is segmented into transcutaneous and implantable.Based on end user, the peripheral nerve stimulators market is segmented into hospitals & clinics, ambulatory centers, specialty center, and others.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8056Key PlayersSome of the major players operating in the global peripheral nerve stimulators market are B. Braun Melsungen AG, NeuroSigma, Inc, NeuroMetrix, Inc., Avanos Pain Management, Enteromedics, ElectroCore, Inc., Vygon SA, Boston Scientific Corporation, Medline Industries, Inc SPR Therapeutics LLC, Stimwave LLC., SUNMED INC., and others.Regional AnalysisGeographically the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.Geographically, The Americas led the market and accounted for the largest share of the peripheral nerve stimulators market in 2017 owing to the increasing prevalence of neurological diseases, aging population, and rising expenses in research and development by healthcare bodies and government.
For instance, in 2017, according to the National SCI Statistical Center, around 288,000 people suffering from spinal cord injury in the US, whereas, 17,700 new spinal cord injury cases are estimated per year.
Moreover, the increasing neurological disease would support regional market growth.
Industry Report “Brugada Syndrome Market Research Report - Forecast to 2023” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, macro economical and governing factors in the Digital Commerce Platform market.Dominant players:Some of the key players in this market are GeneDx (U.S), PGxHealth LLC (U.S), Abbott (U.S), GE Healthcare (U.K), Medtronic (U.S.), Pfizer, Inc (U.S), Boston Scientific Corporation (U.S.), GlaxoSmithKline (U.K), Eli Lilly Company (U.S), Taj Pharmaceuticals Ltd (India), and others.Brugada Syndrome Market OverviewFactors such as the increasing prevalence of heart diseases and rising therapeutics demand are estimated to drive the market growth during the forecast period.
Additionally, advancements in diagnostic technologies boost the market.
However, low awareness and lack of healthcare services in the middle and low-income countries are estimated to restrain the market growth during the projected period.The global Brugada syndrome market is expected to grow at a CAGR of 6.4% during the forecast period.SegmentationThe global Brugada syndrome market is segmented on the basis of diagnosis, treatment, and end-user.On the basis of diagnosis, the market is segmented into electrocardiogram, Electrophysiology (EP) test, genetic testing, and others.
Antiarrhythmic drugs are further sub-segmented into ajmaline, allapinin, ethacizin, flecainide, pilsicainide, procainamide, propafenone, and others.
On the basis of end-user, the market is segmented into hospitals and clinics, surgical centers, diagnostic centers, and others.Get Brugada Syndrome Market Research Report: By Diagnosis (Electrocardiogram, Electrophysiology (Ep) Test, Genetic Testing), Treatment (Implantable Cardioverter-Defibrillator), by End-User (Hospitals & Clinics, Diagnostic Centers) - Global Forecast Till 2023 @ https://www.marketresearchfuture.com/reports/brugada-syndrome-market-5849Regional AnalysisThe Americas dominates the global Brugada syndrome market owing to the increasing prevalence of heart diseases and presence of a well-developed healthcare sector within the region.
Moreover, the increasing healthcare expenditure and presence of key players within the regional boundaries provide a favorable background for market growth.
Global Peripheral Nerve Stimulators Technology Market expected to grow significantly over the forecast period.
It is anticipated that the market held a market value of USD 750.36 million in 2018 and is projected to grow at a CAGR of 7.7% over the forecast period.Peripheral nerve stimulation is commonly known as PNS, and a common method to treat chronic pain.
It includes surgery that places a small electrical device next to one of the peripheral nerves.
Peripheral Nerve Stimulators is expected to grow at a significant growth rate.
The major factors influencing the growth of the market include; rising economic growth, increasing geriatric devices, increasing growth in technological advancement in the field of medical devices, rising neurological disorders, rising incidence of chronic health problems, and others.Peripheral Nerve Stimulators Technology Market Key Players Covered:Some of the major players operating in the global Peripheral Nerve Stimulators Technology Market are,Braun Melsungen AGNeuroSigma IncNeuroMetrix Inc.Avanos Pain ManagementEnteromedicsElectroCore Inc.Vygon SABoston Scientific CorporationMedline Industries IncSPR Therapeutics LLCStimwave LLC.SUNMED INC.and others.Avail a FREE Sample at: https://www.marketresearchfuture.com/sample_request/8056Peripheral Nerve Stimulators Technology Market Segmentation Overview:The global Peripheral Nerve Stimulators Technology Market has been segmented into product, and end user.Based on product, the market is segmented into transcutaneous and implantable.Based on end user, the Peripheral Nerve Stimulators Technology Market is segmented into hospitals & clinics, ambulatory centers, specialty center, and others.Peripheral Nerve Stimulators Technology Market Regional Analysis:Geographically the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.Geographically, The Americas led the market and accounted for the largest share of the Peripheral Nerve Stimulators Technology Market in 2017 owing to the increasing prevalence of neurological diseases, aging population, and rising expenses in research and development by healthcare bodies and government.
For instance, in 2017, according to the National SCI Statistical Center, around 288,000 people suffering from spinal cord injury in the US, whereas, 17,700 new spinal cord injury cases are estimated per year.
Market HighlightsThe Global Phytoestrogen Supplements market is expected to grow at an approximate CAGR of 6.1% during the forecast period, 2018–2023.Phytoestrogens are plant-derived xenoestrogens which are used to address issues associated with the decline of estrogen secretion during menopause.
In recent years, the demands for phytoestrogens have increased owing to the increasing female geriatric population, growing demands for nutraceutical, rising prevalence of acne and increasing awareness regarding women health.
However, risks associated with the consumption and low healthcare expenditure within the middle and low-income countries is estimated to restraint the market growth during the forecast period.Get Free SAmple Copy @ https://www.marketresearchfuture.com/sample_request/6136Regional AnalysisThe Americas dominates the global market for phytoestrogen supplements owing to growing female geriatric population and presence of major market players within the region.
Additionally, the presence of developed economies and healthcare sector within the region fuels the market growth during the forecast period.
In 2017, it was estimated that Europe stood second in the global phytoestrogen supplements market due to increasing prevalence of acne and presence of a well-developed healthcare sector within the region.
On the other hand, the Middle East and Africa holds the least share in the global phytoestrogen supplements market.
OverviewVital signs monitoring devices are used in monitoring the vital signs of a person and prevent the individual’s death in case of dropping vitals.
The global vital signs monitoring market report by Market Research Future (MRFR) has been collated and compiled by researchers backed by thorough primary and secondary research.
It contains pertinent insights, drivers, and threats for the period of 2018 to 2023 (forecast period).Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/6891Market ScopeThe global vital signs monitoring market can showcase returns at a CAGR of 7.5% over the forecast period.
Emergence of wearables for monitoring health and its subsequent adoption in commercial healthcare settings is likely to bode well for the market.
Recently, Nihon Kohden launched a new tool which measures blood pressure, temperature, and blood oxygen levels in patients which will assist physicians in their diagnosis.High costs of devices and stringent regulations pertaining to its approval may impede the global vital signs monitoring market growth.SegmentationThe global vital signs monitoring market has been segmented into product, type, portability, end user and distribution channel.
According to the Population Reference Bureau of 2016, the population aged 65 and above in the U.S. can reach 98 million by 2060.Europe has assumed the second position in the global vital signs monitoring market owing to changing lifestyles, various demographics, and demand for home healthcare.APAC can register the fastest growth rate during the forecast period owing to massive demand for monitoring devices, the large geriatric populace, and high prevalence of chronic diseases.Competitive Outlook Smiths Medical, Medtronic, Omron Healthcare, Inc., CASMED, Natus Medical Incorporated, GENERAL ELECTRIC COMPANY, Masimo, Boston Scientific Corporation, SunTech Medical, Inc., Welch Allyn, Mindray DS USA, Inc., Spacelabs Healthcare, Siemens Healthcare Private Limited, Koninklijke Philips N.V., and Hicks Thermometers India Limited are some of the notable players profiled in the global structural adhesives market.Industry NewsA study conducted by LINK-HF outlining the effects of a wearable sensor by Vital Connect can detect strokes at a preventive stage in heart patients.
